Osteoarthritis Market Segmentation
Osteoarthritis Type Outlook (USD Billion, 2018-2030)
Osteoarthritis Diagnosis Outlook (USD Billion, 2018-2030)
Osteoarthritis Treatment Outlook (USD Billion, 2018-2030)
Osteoarthritis End User Outlook (USD Billion, 2018-2030)
Osteoarthritis Regional Outlook (USD Billion, 2018-2030)
TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Osteoarthritis Market, by Type
6.1 Introduction
6.2 Hip Osteoarthritis
Market Estimates & Forecast, 2022-2030
6.3 Wrist Osteoarthritis
Market Estimates & Forecast, 2022-2030
6.4 Spinal Osteoarthritis
Market Estimates & Forecast, 2022-2030
6.5 Others
Chapter 7. Global Osteoarthritis Market, by Diagnosis
7.1 Introduction
7.2 Imaging
Market Estimates & Forecast, 2022-2030
7.2.1 X-rays
7.2.2 Magnetic resonance imaging (MRI)
7.2.3 Others
7.3 Joint Fluid Analysis
7.2.2. Market Estimates & Forecast, 2022-2030
7.4 Others
Chapter 8. Global Osteoarthritis Market, by Treatment
8.1 Introduction
8.2 Medication
Market Estimates & Forecast, 2022-2030
8.2.1 Analgesics
Market Estimates & Forecast, 2022-2030
8.2.1.1 Acetaminophen
8.2.1.2 Duloxetine
8.2.1.3 Others
8.2.2 Non-steroidal Anti-Inflammatory Drugs
Market Estimates & Forecast, 2022-2030
8.2.2.1 Aspirin
8.2.2.2 Ibuprofen
8.2.2.3 Naproxen sodium and naproxen
8.2.2.4 Others
8.3 Therapies
Market Estimates & Forecast, 2022-2030
8.4 Surgery
Market Estimates & Forecast, 2022-2030
8.5 Others
Chapter 9. Global Osteoarthritis Market, by End Users
9.1 Introduction
9.2 Hospitals & Clinics
Market Estimates & Forecast, 2022-2030
9.3 Medical Institutes
Market Estimates & Forecast, 2022-2030
9.4 Research Organization
Market Estimates & Forecast, 2022-2030
9.5 Others
Chapter 10. Global Osteoarthritis Market, by Region
10.1 Introduction
10.2 America
10.2.1 North America
10.2.1.1 U.S.
10.2.1.1 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.4 Spain
10.3.1.5 U.K
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Republic of Korea
10.4.6 Rest of Asia Pacific
10.5 The Middle East & Africa
10.5.1 United Arab Emirates
10.5.2 Saudi Arabia
10.5.3 Oman
10.5.4 Kuwait
10.5.5 Qatar
10.5.6 Rest of the Middle East & Africa
Chapter 11. Company Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Key Development & Strategies
11.3.1 Key Developments
Chapter 12 Company Profiles
12.1 Abbott.
12.1.1 Company Overview
12.1.2 Product Overview
12.1.3 Financials
12.2.4 Key Developments
12.1.5 SWOT Analysis
12.2 Novartis AG
12.2.1 Company Overview
12.2.2 Product Overview
12.2.3 Financial Overview
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.3 Pfizer Inc.
12.3.1 Company Overview
12.3.2 Product Overview
12.3.3 Financial Overview
12.3.4 Key Development
12.3.5 SWOT Analysis
12.4 Eli Lilly and Company.
12.4.1 Company Overview
12.4.2 Product/Business Segment Overview
12.4.3 Financial Overview
12.4.4 Key Development
12.4.5 SWOT Analysis
12.5 ABIOGEN PHARMA S.p.A
12.5.1 Company Overview
12.5.2 Product Overview
12.5.3 Financial overview
12.5.4 Key Developments
12.5.5 SWOT Analysis
12.6 Merck Sharp & Dohme Corp.
12.6.1 Company Overview
12.6.2 Product Overview
12.6.3 Financial Overview
12.6.4 Key Developments
12.6.5 SWOT Analysis
12.7 TissueGene Inc.
12.7.1 Overview
12.7.2 Product Overview
12.7.3 Financials
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.8 Ampio Pharmaceuticals Inc.
12.8.1 Overview
12.8.2 Product Overview
12.8.3 Financials
12.8.4 Key Developments
12.8.5 SWOT Analysis
12.9 Regeneron
12.9.1 Overview
12.9.2 Product Overview
12.9.3 Financials
12.9.4 Key Developments
12.9.5 SWOT Analysis
12.10 Others
Chapter 13 MRFR Conclusion
13.1 Key Findings
13.1.1 From CEO’s View Point
13.1.2 Unmet Needs of the Market
13.2 Key Companies to Watch
13.3 Prediction of Osteoarthritis Market
Chapter 14 Appendix
LIST OF TABLES
Table 1 Osteoarthritis Industry Synopsis, 2022-2030
Table 2 Global Osteoarthritis Market Estimates and Forecast, 2022-2030, (USD Million)
Table 3 Global Osteoarthritis Market by Region, 2022-2030, (USD Million)
Table 4 Global Osteoarthritis Market by Type, 2022-2030, (USD Million)
Table 5 Global Osteoarthritis Market by Diagnosis, 2022-2030, (USD Million)
Table 6 Global Osteoarthritis Market by Treatment, 2022-2030, (USD Million)
Table 7 Global Osteoarthritis Market by End Users, 2022-2030, (USD Million)
Table 8 North America Osteoarthritis Market by Type, 2022-2030, (USD Million)
Table 9 North America Osteoarthritis Market by Diagnosis, 2022-2030, (USD Million)
Table 10 North America Osteoarthritis Market by Treatment, 2022-2030, (USD Million)
Table 11 North America Osteoarthritis Market by End Users, 2022-2030, (USD Million)
Table 12 U.S. Osteoarthritis Market by Type, 2022-2030, (USD Million)
Table 13 U.S. Osteoarthritis Market by Diagnosis, 2022-2030, (USD Million)
Table 14 U.S. Osteoarthritis Market by Treatment, 2022-2030, (USD Million)
Table 15 U.S. Osteoarthritis Market by End Users, 2022-2030, (USD Million)
Table 16 Canada Osteoarthritis Market by Type, 2022-2030, (USD Million)
Table 17 Canada Osteoarthritis Market by Diagnosis, 2022-2030, (USD Million)
Table 18 Canada Osteoarthritis Market by Treatment, 2022-2030, (USD Million)
Table 19 Canada Osteoarthritis Market by End Users, 2022-2030, (USD Million)
Table 20 South America Osteoarthritis Market by Type, 2022-2030, (USD Million)
Table 21 South America Osteoarthritis Market by Diagnosis, 2022-2030, (USD Million)
Table 22 South America Osteoarthritis Market by Treatment, 2022-2030, (USD Million)
Table 23 South America Osteoarthritis Market by End Users, 2022-2030, (USD Million)
Table 24 Europe Osteoarthritis Market by Type, 2022-2030, (USD Million)
Table 25 Europe Osteoarthritis Market by Diagnosis, 2022-2030, (USD Million)
Table 26 Europe Osteoarthritis Market by Treatment, 2022-2030, (USD Million)
Table 27 Europe Osteoarthritis Market by End Users, 2022-2030, (USD Million)
Table 28 Western Europe Osteoarthritis Market by Type, 2022-2030, (USD Million)
Table 29 Western Europe Osteoarthritis Market by Diagnosis, 2022-2030, (USD Million)
Table 30 Western Europe Osteoarthritis Market by Treatment, 2022-2030, (USD Million)
Table 31 Western Europe Osteoarthritis Market by End Users, 2022-2030, (USD Million)
Table 32 Eastern Europe Osteoarthritis Market by Type, 2022-2030, (USD Million)
Table 33 Eastern Europe Osteoarthritis Market by Diagnosis, 2022-2030, (USD Million)
Table 34 Eastern Europe Osteoarthritis Market by Treatment, 2022-2030, (USD Million)
Table 35 Eastern Europe Osteoarthritis Market by End Users, 2022-2030, (USD Million)
Table 36 Asia Pacific Osteoarthritis Market by Type, 2022-2030, (USD Million)
Table 37 Asia Pacific Osteoarthritis Market by Diagnosis, 2022-2030, (USD Million)
Table 38 Asia Pacific Osteoarthritis Market by Treatment, 2022-2030, (USD Million)
Table 39 Asia Pacific Osteoarthritis Market by End Users, 2022-2030, (USD Million)
Table 40 Middle East & Africa Osteoarthritis Market by Type, 2022-2030, (USD Million)
Table 41 Middle East & Africa Osteoarthritis Market by Diagnosis, 2022-2030, (USD Million)
Table 42 Middle East & Africa Osteoarthritis Market by Treatment, 2022-2030, (USD Million)
Table 43 Middle East & Africa Osteoarthritis Market by End Users, 2022-2030, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Osteoarthritis Market
Figure 3 Market Dynamics for Global Osteoarthritis Market
Figure 4 Global Osteoarthritis Market Share, by Type 2022
Figure 5 Global Osteoarthritis Market Share, by Diagnosis 2022
Figure 6 Global Osteoarthritis Market Share, by Treatment, 2022
Figure 7 Global Osteoarthritis Market Share, by End Users, 2022
Figure 8 Global Osteoarthritis Market Share, by Region, 2022
Figure 9 North America Osteoarthritis Market Share, by Country, 2022
Figure 10 Europe Osteoarthritis Market Share, by Country, 2022
Figure 11 Asia Pacific Osteoarthritis Market Share, by Country, 2022
Figure 12 Middle East & Africa Osteoarthritis Market Share, by Country, 2022
Figure 13 Global Osteoarthritis Market: Company Share Analysis, 2022 (%)
Figure 14 Abbott.: Key Financials
Figure 15 Abbott.: Segmental Revenue
Figure 16 Abbott.: Geographical Revenue
Figure 17 Kinetec: Type UK Ltd: Key Financials
Figure 18 Kinetec: Type UK Ltd: Segmental Revenue
Figure 19 Kinetec: Type UK Ltd: Geographical Revenue
Figure 20 Pfizer Inc.: Key Financials
Figure 21 Pfizer Inc.: Segmental Revenue
Figure 22 Pfizer Inc.: Geographical Revenue
Figure 23 Eli Lilly and Company.: Key Financials
Figure 24 Eli Lilly and Company.: Segmental Revenue
Figure 25 Eli Lilly and Company.: Geographical Revenue
Figure 26 ABIOGEN PHARMA S.p.A: Key Financials
Figure 27 ABIOGEN PHARMA S.p.A: Segmental Revenue
Figure 28 ABIOGEN PHARMA S.p.A: Geographical Revenue
Figure 29 Merck Sharp & Dohme Corp.: Key Financials
Figure 30 Merck Sharp & Dohme Corp.: Segmental Revenue
Figure 31 Merck Sharp & Dohme Corp.: Geographical Revenue
Figure 32 TissueGene Inc.: Key Financials
Figure 33 TissueGene Inc.: Segmental Revenue
Figure 34 TissueGene Inc.: Geographical Revenue
Figure 35 Ampio Pharmaceuticals Inc.: Key Financials
Figure 36 Ampio Pharmaceuticals Inc.: Segmental Revenue
Figure 37 Ampio Pharmaceuticals Inc.:Geographical Revenue
Figure 38 Regeneron: Key Financials
Figure 39 Regeneron: Segmental Revenue
Figure 40 Regeneron.: Geographical Revenue
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
